| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.00▲ | 2.00▲ | 2.01▼ | 2.01▼ | 2.06▼ |
| MA10 | 2.01▼ | 2.01▼ | 2.01▼ | 2.02▼ | 2.06▼ |
| MA20 | 2.01▼ | 2.01▼ | 2.01▼ | 2.06▼ | 2.17▼ |
| MA50 | 2.01▼ | 2.02▼ | 2.02▼ | 2.05▼ | 2.46▼ |
| MA100 | 2.02▼ | 2.05▼ | 2.05▼ | 2.19▼ | 2.47▼ |
| MA200 | 2.05▼ | 2.05▼ | 2.06▼ | 2.35▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.001▲ | 0.001▲ | -0.003▼ | 0.001▲ |
| RSI | 45.601▼ | 44.755▼ | 44.616▼ | 42.649▼ | 39.490▼ |
| STOCH | 27.778 | 33.333 | 44.444 | 15.292▼ | 21.681 |
| WILL %R | -66.667 | -66.667 | -66.667 | -100.000▼ | -93.878▼ |
| CCI | -38.095 | 15.686 | -19.321 | -85.590 | -94.054 |
| ▲ MA | $MRT MA(20) Crossed Above MA(50) | Set Alert |
|
Friday, January 09, 2026 04:53 AM
(RTTNews) - The biotech industry witnessed several key clinical trial data readouts across multiple therapeutic areas, including lung cancer, cardiovascular risk, Alzheimer's, and hepatitis.
|
|
Tuesday, December 16, 2025 06:37 AM
All 20 patients enrolled were evaluable for safety. The combination of MRT-2359 and enzalutamide maintained a favorable safety profile, with manageable, primarily gastrointestinal adverse events that ...
|
|
Wednesday, December 03, 2025 04:00 PM
(RTTNews) - Monte Rosa Therapeutics, Inc. (GLUE) today announced positive interim results from its ongoing Phase 1 study of MRT-8102, a NEK7-directed molecular glue degrader in development for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 2.01 | 2.0163 | 2.00 | 2.00 | 14,108 |
| 01/04/26 | 2.03 | 2.03 | 2.00 | 2.02 | 2,791 |
| 31/03/26 | 2.01 | 2.03 | 2.00 | 2.00 | 11,133 |
| 30/03/26 | 2.05 | 2.05 | 2.00 | 2.01 | 20,084 |
| 27/03/26 | 2.00 | 2.04 | 2.00 | 2.02 | 20,460 |
| 26/03/26 | 2.02 | 2.0599 | 2.02 | 2.05 | 15,774 |
| 25/03/26 | 2.06 | 2.06 | 2.00 | 2.02 | 14,500 |
| 24/03/26 | 2.00 | 2.04 | 2.00 | 2.04 | 15,120 |
| 23/03/26 | 2.00 | 2.0297 | 2.00 | 2.00 | 34,129 |
| 20/03/26 | 2.01 | 2.0299 | 2.00 | 2.00 | 14,868 |
|
|
||||
|
|
||||
|
|